How it works
Vaccines for Tameside and Glossop are being delivered by GP led hubs based on our Primary Care Networks (PCN) - groups of GP practices within a neighbourhood. We therefore have five vaccination hubs where we are delivering the Vaccine locally – Ashton, Hyde, Denton, Stalybridge and Glossop. There are also national vaccination centres and the one for the North-West is based at The Etihad Tennis Club in Manchester.
We are working our way through the JCVI priority groups in Phase One, pictured below, and are currently working our way through Phase Two, which comprises Cohort 10: 40 to 49-year-olds, Cohort 11: 30 to 39-year-olds and Cohort 12: 18 to 29-year-olds. When it is the right time, people will receive an invitation to book an appointment for their vaccine.
Please do not contact the NHS to get an appointment until you hear from the NHS.
For more information on Phase Two, click here.
If you are in the Phase One groups and have not yet been vaccinated it’s not too late. Please book an appointment at your local vaccination hub at www.tamesideandglossop.nhsvaccinations.co.uk or by contacting your GP practice or you can book for the mass vaccination centre at the Etihad via the national booking system at www.nhs.uk/coronavirus-vaccination or by calling 119.
Why the Vaccine is important
Having the vaccine is the best way to protect the most vulnerable people from Covid-19 and has the potential to save thousands of lives – for every 20 vaccinations given, a life is saved!
If you’re a frontline worker in the NHS, you are more likely to be exposed to COVID-19 at work. Getting your COVID-19 vaccination as soon as you can, should protect you and may help to protect your family and those you care for. The COVID-19 vaccine should help reduce the rates of serious illness and save lives and will therefore reduce pressure on the NHS and social care services.
The vaccine will protect you from becoming seriously ill from Covid-19 but you can still catch it and pass it on. And so it is vital that even when you have received your vaccine, you must continue to follow government guidance on social distancing, wearing a face cover and regular handwashing, as well as the additional measures in place in your area.
More Information on the vaccine is available on the www.nhs.uk/covid-vaccination
COVID-19 Vaccine AstraZeneca
COVID-19 Vaccine AstraZeneca stimulates the body’s natural defences (immune system). It causes the body to produce its own protection (antibodies) against the virus. This will help to protect you against COVID-19 in the future. None of the ingredients in this vaccine can cause COVID-19. Adverse events following the Oxford/AstraZeneca vaccine are extremely rare and, for the vast majority of people, the benefits of preventing serious illness and death far outweigh any risks.
The JCVI has reviewed the latest available evidence on extremely rare cases of blood clots and low platelet count following the first dose of the AstraZeneca vaccine. Taking a precautionary approach in relation to the extremely small risk, the JCVI has advised a preference for adults below the age of 40 without underlying health conditions to receive an alternative to the AstraZeneca vaccine – where available and only if this does not cause substantial delays in being vaccinated.
The COVID-19 vaccines are highly effective and have been shown to substantially reduce the risk of death, severe disease and transmission of infection.
For the JCVI statement, please click here. For more information on the vaccine, please click here
COVID-19 Vaccine Moderna
Moderna stimulates the body’s natural defences (immune system). The vaccine works by causing the body to produce its own protection (antibodies) against the virus that causes the COVID-19 infection. It uses a molecule called messenger ribonucleic acid (mRNA) to deliver the set of instructions that cells in the body can use to make antibodies to help fight the virus that causes COVID-19. It cannot give you COVID-19 and will help to protect against COVID-19. For more information on Moderna click here
Variants of concern
Current vaccines were designed for earlier versions of coronavirus, but scientists believe they should still work against mutated versions of coronavirus. Experts are also confident existing vaccines can be redesigned to better tackle emerging mutations.